Shares of a micro-cap pharmaceutical stock rose 5 percent following the approval from the Review Committee on Genetic Manipulation (RCGM) to initiate pre-clinical toxicity studies for its recombinant Erythropoietin product.
Share Price Movement
During Thursday’s trading session, Kwality Pharmaceuticals Ltd’s share price reached an intra-day high of Rs.909.95 per share, a 5 percent increase from the previous close of Rs.867.30 apiece. The shares have retreated since then and currently trading at Rs.281.95 per share. Over the past year, the shares have delivered 76 percent.
What is the news
Kwality Pharmaceuticals Limited (KPL) has announced that it has received approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for its recombinant Erythropoietin product, 10,000 1U/mL, developed in its Biologics Unit.
Erythropoietin, a key treatment for anemia in chronic kidney disease (CKD), marks an important step in expanding the company’s biologics portfolio. The company is preparing for commercialization in the next fiscal after completing the pre-clinical studies.
Product Range
Kwality Pharmaceuticals offers a diverse range of products across several therapeutic categories, including liquid orals, oral suspension powders, tablets, capsules, sterile injections, ointments, and cytotoxic oncology products.
The company also produces effervescent formulations. Adhering to Good Manufacturing Practices (GMP), Kwality Pharmaceuticals holds international accreditations, enabling it to operate in over 60 countries globally.
Also read….
Revenue Segmentation
In FY24, Kwality Pharmaceuticals Ltd’s regional sales distribution was led by LATAM, contributing 60 percent of total sales. Other key regions included Africa (13 percent), Asia (10 percent), GCC (12 percent), and CIS/EU (5 percent).
Financial Overview
In its latest financial update, the company reported net sales of Rs.90.03 crore for Q2 FY25, marking a 30 percent increase from Rs.69.65 crore in Q2 FY24. Additionally, net profits saw a rise of 36 percent, reaching Rs.8.46 crore, compared to Rs.6.22 crore during the same period last year.
About the Company
Kwality Pharmaceuticals Ltd., headquartered in Amritsar, Punjab, India, has been a significant player in the pharmaceutical industry since its establishment in 1983. The company specializes in manufacturing and exporting an extensive array of pharmaceutical formulations.
Written by – Siddesh S Raskar
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
